Vericel Corp VCEL

Healthcare Biotechnology

Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The Company also holds a license for North American rights to NexoBrid (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for the removal of eschar in adults with deep partial-thickness and/or full-thickness burns.

NDAQ:VCEL - Post by User

Vericel Corp

Bullboard Posts

Post by vforvalueon Jun 20, 2008 12:51pm

892 Views

Post# 15209689

Trouble in the marketplace

Aastrom had not regained compliance with Nasdaq Marketplace Rule4310(c)(4) related to the minimum closing bid price of the Company'scommon shares by June 17, 2008.

Aastrom will now be provided an additional 180calendar day compliance period, or until December 15, 2008, to regaincompliance.

Aastrom can regain compliance with the minimum closing bid price ruleanytime before December 15, 2008, if the bid price of its common stockcloses at $1.00 or higher for a minimum of ten consecutive businessdays.

If Aastromdoes not regain compliance during this additional compliance period,Nasdaq will provide written notice to Aastrom that its securities willbe delisted from the Nasdaq Capital Market.

At such time, Aastrom wouldbe able to appeal the delisting determination to a Nasdaq ListingQualifications Panel.

https://www.primenewswire.com/newsroom/news.html?d=144931

ASTM must act fast to save itself

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale